L.L. von Moltke
Division of Clinical Pharmacology
New England Medical Center Hospital
Boston
Massachusetts
USA
Name/email consistency: high
- Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions. von Moltke, L.L., Greenblatt, D.J., Granda, B.W., Grassi, J.M., Schmider, J., Harmatz, J.S., Shader, R.I. Psychopharmacology (Berl.) (1999)
- In vitro approaches to predicting drug interactions in vivo. von Moltke, L.L., Greenblatt, D.J., Schmider, J., Wright, C.E., Harmatz, J.S., Shader, R.I. Biochem. Pharmacol. (1998)
- Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermine. von Moltke, L.L., Greenblatt, D.J., Ciraulo, D.A., Grassi, J.M., Granda, B.W., Duan, S.X., Harmatz, J.S., Shader, R.I. J. Clin. Psychopharmacol (1998)
- Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo. von Moltke, L.L., Greenblatt, D.J., Duan, S.X., Daily, J.P., Harmatz, J.S., Shader, R.I. J. Pharm. Sci (1998)
